Historical shareholding details of
Calamos Advisors LLC
holdings in Gilead Sciences, Inc. (GILD)
Monthly changes of
Calamos Advisors LLC
shareholding in Gilead Sciences, Inc.
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Calamos Advisors Llc
|
250,490
|
0.02%
|
|
Feb 28, 2025
|
Calamos Advisors Llc
|
250,490
|
0.02%
|
|
Jan 31, 2025
|
Calamos Advisors Llc
|
250,490
|
0.02%
|
|
Dec 31, 2024
|
Calamos Advisors Llc
|
232,271
|
0.02%
|
Dec 31, 2024
|
Calamos Advisors Llc
|
250,490
|
0.02%
|
|
Nov 30, 2024
|
Calamos Advisors Llc
|
250,490
|
0.02%
|
|
Oct 31, 2024
|
Calamos Advisors Llc
|
251,556
|
0.02%
|
|
Sep 30, 2024
|
Calamos Advisors Llc
|
232,271
|
0.02%
|
Sep 30, 2024
|
Calamos Advisors Llc
|
257,227
|
0.02%
|
|
Aug 31, 2024
|
Calamos Advisors Llc
|
257,227
|
0.02%
|
|
Jul 31, 2024
|
Calamos Advisors Llc
|
257,949
|
0.02%
|
|
Jun 30, 2024
|
Calamos Advisors Llc
|
237,942
|
0.02%
|
Jun 30, 2024
|
Calamos Advisors Llc
|
266,592
|
0.02%
|
|
May 31, 2024
|
Calamos Advisors Llc
|
266,592
|
0.02%
|
|
Apr 30, 2024
|
Calamos Advisors Llc
|
274,180
|
0.02%
|
|
Mar 31, 2024
|
Calamos Advisors Llc
|
246,645
|
0.02%
|
Mar 31, 2024
|
Calamos Advisors Llc
|
274,374
|
0.02%
|
|
Feb 29, 2024
|
Calamos Advisors Llc
|
274,374
|
0.02%
|
|
Jan 31, 2024
|
Calamos Advisors Llc
|
277,997
|
0.02%
|
|
Dec 31, 2023
|
Calamos Advisors Llc
|
252,818
|
0.02%
|
Dec 31, 2023
|
Calamos Advisors Llc
|
277,997
|
0.02%
|
|
Nov 30, 2023
|
Calamos Advisors Llc
|
277,997
|
0.02%
|
|
Oct 31, 2023
|
Calamos Advisors Llc
|
277,997
|
0.02%
|
|
Sep 30, 2023
|
Calamos Advisors Llc
|
257,585
|
0.02%
|
Sep 30, 2023
|
Calamos Advisors Llc
|
553,857
|
0.04%
|
|
Aug 31, 2023
|
Calamos Advisors Llc
|
555,986
|
0.04%
|
|
Jul 31, 2023
|
Calamos Advisors Llc
|
556,254
|
0.04%
|
|
Jun 30, 2023
|
Calamos Advisors Llc
|
410,208
|
0.03%
|
Jun 30, 2023
|
Calamos Advisors Llc
|
556,013
|
0.04%
|
|
May 31, 2023
|
Calamos Advisors Llc
|
556,213
|
0.04%
|
|
Mar 31, 2023
|
Calamos Advisors Llc
|
410,095
|
0.03%
|
View all ownership details of Gilead Sciences, Inc.